0.4252
Heartbeam Inc stock is traded at $0.4252, with a volume of 919.57K.
It is up +8.22% in the last 24 hours and up +0.05% over the past month.
HeartBeam Inc is a medical technology company focused on developing higher resolution ambulatory electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The company's proprietary and patented technology platform captures the heart's electrical activity from three dimensions and synthesizes a 12-lead ECG from these signals. The company has received U.S. Food and Drug Administration (FDA) clearance for its ECG solutions.
See More
Previous Close:
$0.3929
Open:
$0.4027
24h Volume:
919.57K
Relative Volume:
0.02
Market Cap:
$23.96M
Revenue:
$438.83M
Net Income/Loss:
$-20.23M
P/E Ratio:
-0.7569
EPS:
-0.5618
Net Cash Flow:
$-13.97M
1W Performance:
-12.99%
1M Performance:
+0.05%
6M Performance:
-51.97%
1Y Performance:
-75.98%
Heartbeam Inc Stock (BEAT) Company Profile
Name
Heartbeam Inc
Sector
Industry
Phone
408-899-4443
Address
2118 WALSH AVE., SUITE 210, SANTA CLARA
Compare BEAT vs VEEV, TEM, BTSG, HNGE, HQY
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
BEAT
Heartbeam Inc
|
0.4252 | 23.96M | 438.83M | -20.23M | -13.97M | -0.5618 |
|
VEEV
Veeva Systems Inc
|
311.15 | 50.38B | 3.32B | 941.65M | 1.64B | 5.6161 |
|
TEM
Tempus Ai Inc
|
70.14 | 12.73B | 1.36B | -302.91M | -219.93M | -1.7182 |
|
BTSG
Brightspring Health Services Inc
|
62.17 | 12.30B | 13.65B | 169.86M | 412.12M | 1.0758 |
|
HNGE
Hinge Health Inc
|
105.42 | 8.51B | 646.34M | -512.40M | 202.76M | -6.6871 |
|
HQY
Healthequity Inc
|
92.47 | 7.65B | 1.34B | 230.70M | 440.96M | 2.6695 |
Heartbeam Inc Stock (BEAT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-22-26 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jul-14-26 | Initiated | Maxim Group | Buy |
| Apr-20-26 | Downgrade | D. Boral Capital | Buy → Hold |
| Mar-31-26 | Initiated | B. Riley Securities | Buy |
| Mar-27-26 | Initiated | D. Boral Capital | Buy |
| Mar-16-26 | Downgrade | The Benchmark Company | Buy → Speculative Buy |
| Dec-11-25 | Upgrade | The Benchmark Company | Speculative Buy → Buy |
| Dec-08-25 | Initiated | H.C. Wainwright | Buy |
| Oct-31-25 | Initiated | Roth Capital | Buy |
| Sep-11-20 | Initiated | Needham | Buy |
| Sep-02-20 | Initiated | Robert W. Baird | Neutral |
| Jan-08-20 | Initiated | SunTrust | Buy |
| Aug-02-19 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Apr-26-19 | Reiterated | Dougherty & Company | Buy |
| Jul-26-18 | Reiterated | Lake Street | Buy |
| Apr-26-18 | Reiterated | The Benchmark Company | Buy |
| Feb-23-18 | Reiterated | Dougherty & Company | Buy |
| Nov-08-17 | Reiterated | Dougherty & Company | Buy |
| Oct-26-17 | Initiated | Raymond James | Outperform |
| Oct-24-17 | Initiated | SunTrust | Buy |
| Aug-09-17 | Reiterated | Dougherty & Company | Buy |
| Jul-19-17 | Reiterated | The Benchmark Company | Buy |
| Apr-11-17 | Reiterated | Dougherty & Company | Buy |
| Dec-02-16 | Initiated | Dougherty & Company | Buy |
| Sep-13-16 | Initiated | Sidoti | Buy |
| Aug-03-16 | Reiterated | The Benchmark Company | Buy |
| Jul-28-15 | Reiterated | Dougherty & Company | Buy |
| Oct-24-13 | Initiated | The Benchmark Company | Buy |
| Aug-21-13 | Initiated | Dougherty & Company | Buy |
View All
Heartbeam Inc Stock (BEAT) Latest News
Form 4 Heartbeam Inc For: 10 October By Investing.com - Investing.com South Africa
Form 4 Heartbeam Inc For: 10 October By Investing.com - Investing.com Nigeria
HeartBeam (BEAT) grants Ferrari 90,625 special stock units tied to suspended cash retainers. - Stock Titan
A 37,500-unit special award at HeartBeam (BEAT) accompanies suspended July–December 2026 cash retainers. - Stock Titan
A director receives a 93,750-share option at $0.435 per share from HeartBeam (BEAT). - Stock Titan
HeartBeam (NasdaqCM:BEAT) Stock Forecast & Analyst Predictions - Simply Wall Street
HeartBeam, Inc. (BEAT) Stock Price, News, Quote & History - Yahoo! Finance Canada
Roze AI Inc. Common Shares Expected to Begin Trading on Nasdaq on September 29, 2026 - Yahoo Finance
Host Digital Inc. Announces Common Stock Offering - Yahoo Finance
Annaly Capital Management, Inc. Announces 3rd Quarter 2026 Common Stock Dividend of $0.75 per Share - Yahoo Finance
HeartBeam’s Heart Attack Detection Study Enrollment Completed - Medical Product Outsourcing
BEATW Form 4 FilingsHeartbeam, Inc. Warrant SEC Form 4 - Stock Titan
Healthcare Triangle, Inc. to Distribute Minority Interest of Teyame AI Holdings Inc. Common Shares in Stock Dividend Distribution to HCTI Shareholders, In Connection with its Planned Direct Listing. - Yahoo Finance
Heartbeam Warrant (BEATW) Plunges 32% to $0.01 as Support and Resistance Converge at Penny LevelsHigh Beta Stocks - careplusvn.com
Heartbeam Warrant (BEATW) Plunges 32% to $0.01 as Support and Resistance Converge at Penny LevelsWyckoff Accumulation - dars.gov.et
Heartbeam Warrant (BEATW) Plunges 32% to $0.01 as Support and Resistance Converge at Penny LevelsTrade Entry Signals - dars.gov.et
Heartbeam Inc (BEAT) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
Heartbeam Inc (BEAT) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Heartbeam Inc. Warrant (BEATW) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Heartbeam Warrant (BEATW) Plunges 32% to $0.01 as Speculative Value EvaporatesSynthetic Long - vinanet.vn
Heartbeam Inc. Warrant (BEATW) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
Heartbeam (BEATW) Today: Ends Lower by 26.67% at $0.01; Traders Can Monitor the $0.01-$0.01 Range in the Latest SessionLong Short Pair - vinanet.vn
Heartbeam (BEATW) Update: Closes with Little Net Change at $0.01 in the Latest Reading; Price Setup - vinanet.vn
Heartbeam (BEAT) Shares: Finishes 0.93% Lower at $0.48 for the Current Session; Immediate View - vinanet.vn
Heartbeam (BEAT) Shares: Finishes 0.93% Lower at $0.48 for the Current Session; Immediate View - siam.in
Price to earnings forward of Heartbeam, Inc. – BOATS:BEATW - TradingView
HeartBeam Q2 net loss hits USD 5M - Medical Buyer
HeartBeam enters $25 million at-the-market equity sales agreement with Titan Partners - Investing.com Nigeria
HeartBeam enters $25 million at-the-market equity sales agreement with Titan Partners - Investing.com
HeartBeam enters $25 million at-the-market equity sales agreement with Titan Partners - Investing.com Canada
Form 8K Heartbeam Inc For: 14 August By Investing.com - Investing.com Australia
Form 8K Heartbeam Inc For: 14 August By Investing.com - Investing.com Nigeria
Heartbeam, Inc. Enters Into At-The-Market Equity Offering Sales Agreement For Up To $25 Million In Common Stock - TradingView
HeartBeam enters $25 million at-the-market equity sales agreement with Titan Partners - Investing.com UK
HeartBeam enters $25 million at-the-market equity sales agreement with Titan Partners - Investing.com
Form 8K Heartbeam Inc For: 14 August By Investing.com - Investing.com India
Form 8K Heartbeam Inc For: 14 August By Investing.com - Investing.com Canada
Form 8K Heartbeam Inc For: 14 August By Investing.com - Investing.com UK
Medical Journal Article Highlights Technology’s Potential to Detect Heart Attack Risk at Home - Medical Product Outsourcing
Heartbeam Inc. (BEAT) Slides 7.2% to $0.55 as Selling Pressure MountsVolatility Term Structure - Vinanet
HeartBeam, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Heartbeam Warrant (BEATW) Slides 3.6% as Shares Trade at Penny LevelsMESA MA - vinanet.vn
HeartBeam wins U.S. patent for acoustic sensing, impedance - scanx.trade
Fermi Inc. Common Stock Q2 2026 Earnings Call Summary - Yahoo Finance
HeartBeam Inc (BEAT) (Q2 2026) Earnings Call Highlights: FDA Submission Advances and Commercial ... - Investing.com Canada
HeartBeam Inc (BEAT) (Q2 2026) Earnings Call Highlights: FDA Submission Advances and Commercial ... - Yahoo! Finance Canada
Heartbeam earnings missed by $1.01, revenue fell short of estimates - Investing.com Canada
HeartBeam posts wider Q2 loss than expected, shares inch lower - Investing.com
HeartBeam Q2 slides show clinical progress despite wider Q2 2026 loss By Investing.com - Investing.com India
HeartBeam Q2 slides show clinical progress despite wider Q2 2026 loss By Investing.com - Investing.com Australia
Heartbeam Inc Stock (BEAT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Heartbeam Inc Stock (BEAT) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Elfrink Willem | Director |
Apr 16 '26 |
Buy |
0.80 |
187,500 |
150,000 |
538,667 |
| JAFF MICHAEL R | Director |
Apr 16 '26 |
Buy |
0.80 |
31,250 |
25,000 |
31,250 |
| Vajdic Branislav | Director |
Apr 16 '26 |
Buy |
0.80 |
31,250 |
25,000 |
909,914 |
| Ferrari Richard | Director |
Apr 16 '26 |
Buy |
0.80 |
62,500 |
50,000 |
291,636 |
| ENO Robert Paul | President |
Apr 16 '26 |
Buy |
0.80 |
12,500 |
10,000 |
36,742 |
| Ortigas-Wedekind Marga | Director |
Apr 16 '26 |
Buy |
0.80 |
25,000 |
20,000 |
137,293 |
| STROME MARK E | Director |
Apr 16 '26 |
Buy |
0.80 |
750,000 |
600,000 |
3,650,000 |
| de Urioste George | Director |
Dec 18 '25 |
Sale |
2.83 |
33,185 |
93,914 |
0 |
| STROME MARK E | 10% Owner |
Dec 17 '25 |
Sale |
3.58 |
250,000 |
895,000 |
2,900,000 |
| de Urioste George | Director |
Dec 17 '25 |
Sale |
3.68 |
23,961 |
88,176 |
33,185 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):